The company said its Annual Meeting of Shareholders will be webcast live on May 15, 2025 at 9 a.m. ET and can be viewed online on the Labcorp Investor Relations website.

8-KRegulation FD DisclosureFiled May 8, 2025Period of report May 8, 2025Summary published (UTC) Oct 15, 2026

Key points

AI summary

The company said its Annual Meeting of Shareholders will be webcast live on May 15, 2025 at 9 a.m. ET and can be viewed online on the Labcorp Investor Relations website.
Labcorp said an archived replay of the annual shareholder meeting webcast will be available for 1 year.
Labcorp disclosed the webcast schedule in this 8-K under Item 7.01, Regulation FD Disclosure, and attached a press release dated May 8, 2025 as Exhibit 99.1.
The company said it has nearly 70,000 employees serving clients in approximately 100 countries and performs more than 700 million tests annually. It also said it provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Annual Shareholder Meeting Webcast Schedule

The company said its Annual Meeting of Shareholders will be webcast live on May 15, 2025 at 9 a.m. ET and can be viewed online on the Labcorp Investor Relations website.

Source · Based on the filing body and exhibits

Webcast Replay Availability Period

Labcorp said an archived replay of the annual shareholder meeting webcast will be available for 1 year.

Source · Based on the filing body and exhibits

Filing Format and Press Release

Labcorp disclosed the webcast schedule in this 8-K under Item 7.01, Regulation FD Disclosure, and attached a press release dated May 8, 2025 as Exhibit 99.1.

Source · Based on the filing body and exhibits

Employee Count and Testing Scale in Company Overview

The company said it has nearly 70,000 employees serving clients in approximately 100 countries and performs more than 700 million tests annually. It also said it provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.